Replies to post #20513 on NanoViricides Inc. (NNVC)

[Ubertino]

Whence and how fast:

--Of course, these are not simple tasks. But there is a precedent for new approaches leading to better results. In the early 1990s, as the nation searched for drugs to combat diseases such as HIV/AIDS, the FDA was willing to take some more risks, and there was a spike of drug approvals as it looked more towards effectiveness rather than risk aversion. In this decade, however, the public, Congress, and the media have become more risk averse. In the coming years, we need to determine how to balance maximizing safety without stifling lifesaving innovation.

Coming up with appropriate answers to these types of questions will be essential if we want to ensure that the United States remains the world’s leader in fostering new medical technologies.

Tevi Troy is a Visiting Senior Fellow at Hudson Institute and is the former Deputy Secretary of the Department of Health and Human Services--

http://www.hudson.org/index.cfm?fuseaction=publication_details&id=6177

[Smooth]

Yes, we COULD get a boost of exposure about our virus neutralizing technology that could make the next few weeks or longer, very interesting to the PPS>

I've always felt that when/if the street ever gets wind of our technology and it's ability to fight and neutralize SO MANY viruses, then the PPS could absolutely skyrocket. I mean,it's not too difficult to do the math that would get NNVC to $5-$9 per share in earnings from say 15 viruses. Put a 20 P/E on that, and it's just too exciting and realistic to imagine what the stock might do near term.

What if the stock runs to just 10% of it's future potential(that is when it's actually proven to work and is making money?). Is $10 (20 P/E x $5 x 10%)near term unrealistic?

I'm not predicting this of course, but a huge run here is not out of the question if this swine flu turns a spot light on NNVC. I'll be more than interested in the interview that Seymour will be doing with the new bio-fund that is now recommending us...near term target $2.50, longer term $5.

[Blither]

From everything i have read and learned about the NNVC drugs and the company, the stuff works and can easily take care of this and all other flus, however the problem right now is the ability to mass produce. It will take at least a year or more to understand the process to mass produce the drugs (these things just take time), along with setting up a facility to make it. Yes, money is needed by nnvc to set a facility up (my guess is $15-$30M) and frankly if this swine flu gets enough press and attention for a long enough period of time, getting the money will happen because the govt will figure out a way to give it to the Dr. S, the problem now is just time. It is just going to take time for everything to happen, now because the drug does not work, but because the company needs a place to mass produce and it takes time to build. While this whole swine flu is a terrible thing, it is just NNVC needs to get the attention of the CDC, NIH, WHO, DOD and others groups who will need our drug and be willing to assist on the funding side and the approval expedition side.

I have never felt better about owning any stock, and if you are willing to wait, probably 2-4 years, this will be life changing company both in the world of medicine and in our individual pocket books.